The global market for Biopreservation was valued at US$5 Billion in 2024 and is projected to reach US$7.9 Billion by 2030, growing at a CAGR of 8% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The application of biopreservation is particularly noteworthy in biobanking and regenerative medicine, sectors that heavily rely on these technologies for stem cell preservation and the manufacturing of cell therapies compliant with Good Manufacturing Practices (GMP). Biopreservation supports the intricate requirements of maintaining 'living drugs' through their lifecycle, optimizing preservation media to meet regulatory standards and ensure successful commercialization. This is crucial in regenerative medicine where the viability of cell therapies must be maintained from collection through to administration. Moreover, low-temperature storage methods, like cryogenic and hypothermic storage, play a pivotal role in this regard by reducing metabolic rates and minimizing biochemical requirements, which is vital for preserving cellular function and integrity during storage.
Biopreservation technologies play a crucial role in extending the functional lifespan of biological materials such as cells, tissues, and organs, essential for a broad range of medical and scientific applications. This field has experienced significant growth due to advancements in preservation methods, increased government and private funding for healthcare research, and a rising demand across various medical and research sectors. Particularly beneficial in the realms of immunotherapies, vaccine production, and enzyme technology, biopreservation helps address the growing incidence of chronic diseases by maintaining the viability and functionality of biological materials. Furthermore, the technology incorporates sophisticated tools like microarrays and predictive models which streamline the preservation processes, enhancing diagnosis and treatment capabilities, especially in critical areas such as cardiology and gynecology.
Global Biopreservation Market - Key Trends and Drivers Summarized
Several growth drivers are propelling the biopreservation market, including technological advancements that improve the efficiency of biological material storage, the expansion of R&D in biotechnology and medicine, and the increasing prevalence of chronic diseases that necessitate advanced therapeutic solutions. The expansion of biobanks globally, which requires robust biopreservation to maintain the integrity of biological samples, along with significant governmental and private funding, further fuels this growth. Additionally, stringent regulatory requirements necessitate reliable biopreservation solutions to ensure that biologically derived therapeutic products are safe and effective for clinical use. Innovations like improved cryopreservation technologies and novel media formulations that enhance cell viability and recovery rates are also crucial. As the field evolves, the integration of these technological advancements with increased healthcare investments underscores the crucial role of biopreservation in advancing healthcare and research, promising continued expansion and innovation in the preservation and utilization of vital biological resources.The application of biopreservation is particularly noteworthy in biobanking and regenerative medicine, sectors that heavily rely on these technologies for stem cell preservation and the manufacturing of cell therapies compliant with Good Manufacturing Practices (GMP). Biopreservation supports the intricate requirements of maintaining 'living drugs' through their lifecycle, optimizing preservation media to meet regulatory standards and ensure successful commercialization. This is crucial in regenerative medicine where the viability of cell therapies must be maintained from collection through to administration. Moreover, low-temperature storage methods, like cryogenic and hypothermic storage, play a pivotal role in this regard by reducing metabolic rates and minimizing biochemical requirements, which is vital for preserving cellular function and integrity during storage.
Biopreservation technologies play a crucial role in extending the functional lifespan of biological materials such as cells, tissues, and organs, essential for a broad range of medical and scientific applications. This field has experienced significant growth due to advancements in preservation methods, increased government and private funding for healthcare research, and a rising demand across various medical and research sectors. Particularly beneficial in the realms of immunotherapies, vaccine production, and enzyme technology, biopreservation helps address the growing incidence of chronic diseases by maintaining the viability and functionality of biological materials. Furthermore, the technology incorporates sophisticated tools like microarrays and predictive models which streamline the preservation processes, enhancing diagnosis and treatment capabilities, especially in critical areas such as cardiology and gynecology.
Report Scope
The report analyzes the Biopreservation market, presented in terms of market value (USD). The analysis covers the key segments and geographic regions outlined below.Segments
Product Type (Biopreservation Media, Biopreservation Equipment); Biospecimen (Human Tissue Samples, Organs, Stem Cells, Other Biospecimens); Application (Therapeutic Applications, Research Applications, Clinical Trials, Other Applications); End-Use (Biobanks, Gene Banks, Hospitals, Other End-Uses).Geographic Regions/Countries
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.Key Insights:
- Market Growth: Understand the significant growth trajectory of the Biopreservation Media segment, which is expected to reach US$5.1 Billion by 2030 with a CAGR of a 8.7%. The Biopreservation Equipment segment is also set to grow at 6.6% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $1.3 Billion in 2024, and China, forecasted to grow at an impressive 11.9% CAGR to reach $2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Biopreservation Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Biopreservation Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Biopreservation Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Atlanta Biologicals, Inc., BioCision, LLC, BioGenix, LLC, BioLife Solutions, Inc., Biomatrica, Inc. and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 27 companies featured in this Biopreservation market report include:
- Atlanta Biologicals, Inc.
- BioCision, LLC
- BioGenix, LLC
- BioLife Solutions, Inc.
- Biomatrica, Inc.
- LabVantage Solutions, Inc.
- Panasonic Corporation
- Qiagen, Inc.
- Thermo Fisher Scientific, Inc.
- VWR International LLC
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Atlanta Biologicals, Inc.
- BioCision, LLC
- BioGenix, LLC
- BioLife Solutions, Inc.
- Biomatrica, Inc.
- LabVantage Solutions, Inc.
- Panasonic Corporation
- Qiagen, Inc.
- Thermo Fisher Scientific, Inc.
- VWR International LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 178 |
| Published | February 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 5 Billion |
| Forecasted Market Value ( USD | $ 7.9 Billion |
| Compound Annual Growth Rate | 8.0% |
| Regions Covered | Global |
![Biopreservation Market by Product (Media [Cryopreservation, Hypothermic]), Equipment (Freezers, Refrigerators, Incubators, Centrifuge, Accessories), Biospecimen (Tissues, Organs, Stem Cells), Application (Research, Therapeutic) - Forecast to 2029 - Product Image](http://www.researchandmarkets.com/product_images/11622/11622592_60px_jpg/biopreservation_market.jpg)
